Wockhardt
Top 10 stocks that made news today: Amtek Auto, Unitech, BHEL and more
Amtek Auto Shares ended 5.63 per cent down at Rs 27.65 after the company reported net loss of Rs 132.15 crore for the quarter ended December 31, 2015 as compared to net profit of Rs 70.81 crore for the same quarter in the pre
US FDA observations for Shendra facility not critical: Wockhardt
According to the company, half of the issues will be resolved in next fortnight The nine observations received by Wockhardt for its Shendra facility in Aurangabad from the US health regulator are not ‘critical’ in
USFDA observations for Shendra facility not critical: Wockhardt
The facility, which produces various products including ointments, capsules and tablets, currently caters to the UK and Ireland markets.
USFDA makes 9 observations over Wockhardt’s plant in Aurangabad
The USFDA has made nine 'observations' highlighting violations of its norms at homegrown drug maker Wockhardt's new facility at Shendra in Aurangabad.
Wockhardt falls more than 10% on reports over US FDA notice
Wockhardt shares fell as much as 12.69 per cent intraday on Friday on reports the company has received a notice from the US Food and Drug Administration
Wockhardt receives QIDP status from US FDA
WCK 5222 is a new class of antibiotic for gram negative terrain for complicated urinary tract infections and HABP/ VABP Wockhardt announced that US Food and Drug Administration (US FDA) has granted WCK 5222, a product from th
Wockhardt gets QIDP status for new antibiotic product from FDA
Drug maker Wockhardt has received qualified disease product (QIDP) status from US health regulator for a new antibiotic.
Wockhardt’s Chikalthana plant gets GMP certificate from UKMHRA
The UK regulator had in October 2013 withdrawn the GMP certificate to the Chikalthana plant Wockhardt’s Chikalthana plant at Aurangabad in Maharashtra has received a good manufacturing practice (GMP) certificate from th
Wockhardt gets exemption from price control for three insulin products
The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013 Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has exempted Wockhardt’s three insulin product
NPPA exempts Wockhardt’s 3 insulin products from price control
Wockhardt had applied to the National Pharmaceutical Pricing Authority (NPPA) for non-application of price control provisions of the DPCO 2013 on the three drugs.
Wockhardt posts consolidated revenue of Rs 1231 crore in quarter ended Sept 30, 2015
EBIDTA was at Rs 201 crore
Wockhardt Q2 net zooms to Rs 108 crore
Wockhardt today reported a multi-fold jump in consolidated net profit at Rs 107.59 crore for the second quarter ended September 30, mainly on account of robust sales and lower tax expense.
Wockhardt shares gain after UK MHRA says no critical observations at drug plant
Wockhardt shares were trading over 2 per cent up after the company said that UK's health regulator Medicines and Healthcare Products Regulatory Agency has found "no critical observations" at its L-1 Chikalthana drug manufactu
Why Indian pharma stocks are performing better than their global counterparts
The double-digit stock market gains of Indian pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year.
Sun Pharma, Wockhardt recall drugs from US market
Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt’s recall was under class-II classification Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of
Wockhardt’s consolidated revenue for Q1FY16 grows by 15 per cent at Rs1141 crore
EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial year 2016. The company’s turnover during the quarter grew by 15 per cent on strong growth in the UK and India busines
Wockhardt recalls over 50 lakh bottles of various drugs in US
Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer.
Wockhardt recalls over 1.62 lakh cartons of drugs in US
Drug firm Wockhardt is recalling 1,62,142 cartons of various drugs, which are used to treat ailments like high blood pressure and ulcer, in the US market due to deviations in current good manufacturing practice norms laid dow
